1. The Third World Congress in Nuclear Medicine and Biology;A Yokoyama,1982
2. Yokoyama A, Yamada A, Arano Y, Horiuchi K, Yamamoto K, Torizuka K. Tc-99m bifunctional radiopharmaceutical from a glucose derivatives: A potential agent for brain study. In: Deutsch E, Nicolini M, Wagner Jr H, eds.Technetium in Chemistry and Nuclear Medicine. New York: Raven Press, 1983; 1051–1053.
3. Yokoyama A, Hosotani T, Arano Y, Horiuchi K, Yamamoto K, Torizuka K. Development of Tc-99m-phenylalkylamine bifunctional radiopharmaceuticals for myocardial imaging. In: Deutsch E, Nicolini M, Wagner Jr H, eds.Technetium in Chemistry and Nuclear Medicine, New York: Raven Press, 1983; 1067–1069.
4. Davison A, Jones AG, Orvig C, Sohn M. A new class of oxotechnetium (5+) chelate complexes containing a TcON2S2 core.Inorg Chem 1981; 20: 1629–1632.
5. Abrams MJ, Davison A, Jones AG, Costello CE, Pang H. Synthesis and Characterization of hexakis(alkylisocyanide) and hexakis(arylisocyanide) complexes of Technetium(I).Inorg Chem 1983; 22: 2798–2800.